Biodata and bioinformatics at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
33 organizations at FoG London 2027 present work in biodata & bioinformatics: 14 suppliers and service providers, 11 NHS, government and non-profit bodies and 8 universities and research institutes. Between them they bring 71 presentations to the program. Most represented: University of Oxford, University of Edinburgh and Francis Crick Institute. As of Oct 29, 2026.
Format
Top represented
Showing 1–5 of 33 organizations
| Organization | FoG London 2027 Attendance |
|---|---|
University of Oxford Oxford, UK | |
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research. | Talk Wed Jan 27 11:30–12:00 Why Do We Sleep? Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health. Population & social genomics Talk Wed Jan 27 12:30–13:00 Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent. Talk Wed Jan 27 14:30–15:00 Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles. Talk Wed Jan 27 14:30–15:00 Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread. Talk Wed Jan 27 16:30–17:00 Accelerating the Development of Therapies for Rare Genetic Disease How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases. Talk Wed Jan 27 16:30–17:00 The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics. Talk Wed Jan 27 16:30–17:00 The Body Clock in Your Blood: Circadian Signals in Omics Research How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies. Talk Wed Jan 27 17:30–18:00 Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines. Talk Thu Jan 28 11:30–12:00 Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures. Talk Thu Jan 28 12:30–13:00 Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating. Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Talk Thu Jan 28 14:10–14:40 Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them. Talk Thu Jan 28 14:10–14:40 Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes. Talk Thu Jan 28 14:10–14:40 Why Endometriosis Is Not One Disease: Insights from Genetics How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets. Workshop Thu Jan 28 14:10–15:40 Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation Multi-omics & proteomics Talk Thu Jan 28 14:40–15:10 Talk Thu Jan 28 15:10–15:40 Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Talk Thu Jan 28 16:10–16:40 Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it. Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease Talk Thu Jan 28 16:40–17:10 Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working. Talk Thu Jan 28 16:40–17:10 Leveraging Big Data to Inform Cardiovascular Precision Medicine How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment. |
University of Edinburgh Edinburgh, UK | |
Public research university in Edinburgh, Scotland, with a medical school, the Institute of Genetics and Cancer and the Roslin Institute for animal sciences. | Talk Wed Jan 27 11:30–13:00 Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes AI in drug discovery & diagnostics Talk Wed Jan 27 16:30–17:00 Four Nations Data Linkage in Longitudinal Research - Opportunities and Challenges What it takes to link long-running population studies across England, Scotland, Wales and Northern Ireland into richer research datasets. Talk Wed Jan 27 17:00–17:30 Beyond the Majority: Rethinking Treatment for Rare Ovarian Cancer Subtypes Why rarer ovarian cancer subtypes are understudied, and how genomic insights and newer drugs could improve their treatment. Talk Thu Jan 28 12:00–12:30 Using Epigenetic Signatures to Predict Ageing and Disease Risk How DNA methylation marks can estimate ageing and disease risk, and reveal effects of pollution, smoking and vaping in large cohorts. Talk Thu Jan 28 12:30–13:00 Developing a Clinically Useful Blood Test for Earlier Brain Tumour Diagnosis How a blood test using infrared light could catch brain tumours earlier, and what good diagnostic accuracy means in practice. Talk Thu Jan 28 14:10–14:40 3D Genome Organisation and Gene Regulation: Understanding the Non-Coding Genome How the three-dimensional folding of chromosomes brings distant control regions into contact with genes, and what this reveals about non-coding DNA. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease |
Francis Crick Institute London, UK | |
Biomedical research institute in London founded by the Medical Research Council, Cancer Research UK, Wellcome and three London universities. | Talk Wed Jan 27 11:30–12:00 Cell Identity, Plasticity and Therapeutic Vulnerabilities in Cancer Why the same cell signals cause different behaviours in different tissues, and how cancer cells' identity shapes their response to targeted drugs. Talk Wed Jan 27 16:30–17:00 4,500 Ancient Genomes: Sequencing Human Evolution Through Time How sequencing thousands of ancient genomes traces human migration, natural selection and changing genetic risk for modern diseases such as coeliac disease. Population & social genomics Talk Wed Jan 27 16:30–17:00 Decoding the Mechanisms Behind Immune Infiltration and Spatial Organisation in Tumours How computational methods map where immune cells gather in colorectal tumours, and why those patterns link to patient outlook and treatment response. Talk Thu Jan 28 09:45–10:00 The Next Breakthrough won't happen in a Silo: Reinventing Life Sciences Partnerships in the Age of AI Why AI and genomics call for closer partnerships between universities, drug companies and hospitals to speed discovery and patient care. AI in drug discovery & diagnosticsBiodata & bioinformatics Workshop Thu Jan 28 11:30–13:00 Agentic AI for Single-Cell Genomics AI in drug discovery & diagnosticsSingle-cell genomics Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics |
UK health research programme recruiting millions of adult volunteers who share health data and blood samples to study prevention and early detection. | Booth Exhibiting at Booth 106B Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics Talk Wed Jan 27 14:30–15:00 Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust. Talk Wed Jan 27 14:30–15:00 From Risk Prediction to Precision Prevention How large population cohorts let researchers study disease risk before symptoms appear, to find biomarkers and build evidence for prevention. Talk Wed Jan 27 14:30–16:00 Trust in the Data Age: Who Should Access Our Genomic Data and Why? Biodata & bioinformaticsPopulation & social genomics Talk Thu Jan 28 12:00–12:30 Finding The Right Participants For The Right Research How matching people by clinical, genetic or risk profile to suitable studies could speed recruitment for precision clinical research. |
Genomics England London, UK | |
Government-owned company providing whole-genome sequencing for the NHS Genomic Medicine Service and research, including the Generation newborn study. | Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics Talk Wed Jan 27 14:30–15:00 Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust. Talk Wed Jan 27 14:30–15:00 The Generation Study: Insights From a National Study of Newborn Genome Sequencing What a national study sequencing newborn genomes has learned so far about recruitment and results, and what it means for newborn screening. Talk Thu Jan 28 14:40–15:10 The Genomics England Adult Population Programme How Genomics England is designing a genomics programme for the adult population, what public engagement has taught, and its future plans. |
Find buyers in biodata & bioinformatics
Tell us what you sell and we’ll find the people at organizations working on biodata & bioinformatics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse FoG London 2027 by
Organization type
Topic
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Exhibit hall
Everyone
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction